My SciELO
Services on Demand
Journal
Article
Indicators
- Cited by SciELO
- Access statistics
Related links
- Cited by Google
- Similars in SciELO
- Similars in Google
Share
Avances en Periodoncia e Implantología Oral
On-line version ISSN 2340-3209Print version ISSN 1699-6585
Abstract
LOPEZ LOPEZ, J. et al. Chitosan and chlorhexidine (Bexident®Post) in controlling postoperative pain and inflammation in oral implantology: pilot study. Avances en Periodoncia [online]. 2015, vol.27, n.2, pp.81-89. ISSN 2340-3209. https://dx.doi.org/10.4321/S1699-65852015000200005.
Objectives: Evaluation of the effectiveness of chitosán and chlorhexidine in controlling postoperative pain and inflammation in oral implant surgery. Material and methods: A prospective pilot clinical study in patients with implants. Bexident®Post gel are prescribed three times a day during 7 days to all patients. Inflammation, bucal opening, level of pain, degree of healing and opinion about the product are valued. Results: 138 implants were placed in 54 patients. 64% were males and the mean operative time was 76 minutes. The inflammation, pre and post-operative mouth opening are not significant at p= 0.000. 11 analgesic units have been consumed on average during 7 days of post-operative. The EVA was 3.0 (SD= 2.0) at 6 hours, 2.0 (SD= 2.0) at 24 hours, 2.02 (SD= 1.0) the second day, 1.0 (SD= 1.0) the third and fourth day and 0.0 the fifth, sixth and seventh day. The degree of healing is good in 88.9% (48 patients), fair in 7.4% (4 patients) and bad in 3.7% (2 patients). 45 patients (83%) respond positively to al questions regarding the product. Conclusions: The product is shown as easy to use, the taste is right and in this study, inflammation, pain and medicine use have been minimal. Double-blind study is needed in order to evaluate its effectiveness.
Keywords : Chitosán; chlorhexidine; bexident®post; implants; oral surgery.